EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Hipercolesterolemia familiar: serie de 36 casos con fenotipo de hipercolesterolemia familiar homocigótica

Álvaro J. Ruiz, Luisa Fernanda Patiño, Kelly Amaya, Juan Esteban Gómez, Felipe Ordóñez, Samuel Paternina, Misael Mercado, Harry Pachajoa, Rafael Campo, Gustavo Giraldo, Ravagly Jiménez, Nohora Zuluaga und 11 weitere

Revista Colombiana de Cardiología · 2020-11 · 27 (6) · 498-507

DOI: 10.1016/j.rccar.2019.10.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Colombiana de Cardiología, 2020-11. Verfasst von Álvaro J. Ruiz und 22 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Homozygous familial hypercholesterolemia (HoFH) is characterized for very high levels of cLDL and early cardiovascular disease. Although incidence is low (1/300 000), complications are very severe and can be avoided. Finding and treating this population promptly could reduce mortality. We describe 36 cases in Colombia, where 160 to 200 cases are expected.

Results

36 patients with phenotype of HoHF were identified and treated in a follow-up of 4 years. The mean age was 27 years (24 women). 34 of them had at least 8 points in the FH Dutch Lipid Clinic Criteria (definitive diagnosis) and two had probable diagnosis. A quarter of the cases came from the Colombian North Coast. In molecular tests, 14 were true homozygous for LDLR, 12 were compound heterozygous for LDLR, 2 double heterozygous and one was autosomal recessive; 5 were heterozygous and 2 patients did not authorized genetic test. In true homozygous subjects, the most frequent variant was c.11G>A. 14 patients had coronary disease, 9 carotid stenosis, 8 aortic stenosis and 2 had stroke. 34 patients were on statins (25 rosuvastatin), 30 were receiving ezetimibe, 2 were receiving a PSCK9 inhibitor (evolocumab) and 20 were on lomitapide with mean doses of 12.7mg. None received lipoprotein apheresis. Medications were very well tolerated. Changes in cLDL after therapy was from 533.7 mg/dL to 245 mg/dL, (54%).

Conclusions

Treatment was started in all patients. We found genetic mutations in all patients with genetic tests. The high levels of cLDL mean such a high risk that treatment must be started promptly, even without a genetic test.

Zitieren

APA

Ruiz, Á. J., Patiño, L. F., Amaya, K., Gómez, J. E., Ordóñez, F., Paternina, S., Mercado, M., Pachajoa, H., Campo, R., Giraldo, G., Jiménez, R., Zuluaga, N., Monroy, J., Gil-Forero, J., Matallana, A., Rivera, C., Coll, M., Peña-Vargas, W. A., Manjarrez, O., …, & García, H. (2020). Hipercolesterolemia familiar: serie de 36 casos con fenotipo de hipercolesterolemia familiar homocigótica. Revista Colombiana de Cardiología, 27(6), 498-507. https://doi.org/10.1016/j.rccar.2019.10.006

Vancouver

Ruiz ÁJ, Patiño LF, Amaya K, Gómez JE, Ordóñez F, Paternina S, et al. Hipercolesterolemia familiar: serie de 36 casos con fenotipo de hipercolesterolemia familiar homocigótica. Revista Colombiana de Cardiología. 2020;27(6):498-507. doi:10.1016/j.rccar.2019.10.006

BibTeX
@article{Ruiz2020,
  author = {Ruiz, Álvaro J. and Patiño, Luisa Fernanda and Amaya, Kelly and Gómez, Juan Esteban and Ordóñez, Felipe and Paternina, Samuel and Mercado, Misael and Pachajoa, Harry and Campo, Rafael and Giraldo, Gustavo and Jiménez, Ravagly and Zuluaga, Nohora and Monroy, Jeniffer and Gil-Forero, Julián and Matallana, Audrey and Rivera, Carolina and Coll, Mauricio and Peña-Vargas, William A. and Manjarrez, Octavio and Toro, Juan Martín and Barrera, Álvaro and Hoyos, Diego and García, Harold},
  title = {Hipercolesterolemia familiar: serie de 36 casos con fenotipo de hipercolesterolemia familiar homocigótica},
  journal = {Revista Colombiana de Cardiología},
  year = {2020},
  volume = {27},
  number = {6},
  pages = {498--507},
  doi = {10.1016/j.rccar.2019.10.006}
}
Kostenlos starten →